RhumbLine Advisers’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102M Buy
257,527
+17,179
+7% +$4.89M 0.08% 214
2026
Q1
$41.7M Sell
240,348
-5,592
-2% -$1.15M 0.04% 413
2025
Q4
$63M Sell
245,940
-5,421
-2% -$1.42M 0.05% 289
2025
Q3
$65.4M Sell
251,361
-49
-0% -$12.9K 0.05% 281
2025
Q2
$61.5M Buy
251,410
+5,373
+2% +$1.34M 0.05% 295
2025
Q1
$65.1M Buy
246,037
+7,909
+3% +$2.14M 0.06% 268
2024
Q4
$60.4M Sell
238,128
-9,522
-4% -$2.55M 0.05% 284
2024
Q3
$78.4M Sell
247,650
-12,706
-5% -$4.52M 0.07% 230
2024
Q2
$97.3M Sell
260,356
-14,589
-5% -$4.93M 0.09% 178
2024
Q1
$95.3M Buy
274,945
+8,423
+3% +$3.19M 0.09% 194
2023
Q4
$122M Sell
266,522
-1,815
-0.7% -$895K 0.13% 134
2023
Q3
$131M Sell
268,337
-13,628
-5% -$6.4M 0.15% 116
2023
Q2
$126M Buy
281,965
+2,284
+0.8% +$1.15M 0.14% 123
2023
Q1
$136M Buy
279,681
+12,564
+5% +$6.21M 0.17% 108
2022
Q4
$137M Buy
267,117
+7,682
+3% +$4.04M 0.18% 106
2022
Q3
$126M Buy
259,435
+8,882
+4% +$4.32M 0.19% 96
2022
Q2
$117M Buy
250,553
+1,327
+0.5% +$590K 0.17% 105
2022
Q1
$108M Sell
249,226
-3,312
-1% -$1.39M 0.14% 129
2021
Q4
$117M Buy
252,538
+5,031
+2% +$2.23M 0.14% 122
2021
Q3
$96.3M Sell
247,507
-7,999
-3% -$3.4M 0.13% 134
2021
Q2
$113M Sell
255,506
-5,805
-2% -$2.54M 0.15% 119
2021
Q1
$110M Sell
261,311
-20,371
-7% -$8.13M 0.15% 122
2020
Q4
$116M Sell
281,682
-17,575
-6% -$7.31M 0.16% 120
2020
Q3
$124M Buy
299,257
+22,571
+8% +$9.08M 0.19% 97
2020
Q2
$107M Buy
276,686
+22,489
+9% +$8.41M 0.18% 107
2020
Q1
$79.8M Buy
254,197
+2,666
+1% +$899K 0.17% 120
2019
Q4
$92.2M Sell
251,531
-1,517
-0.6% -$481K 0.15% 129
2019
Q3
$64.7M Buy
253,048
+29,704
+13% +$8.33M 0.12% 164
2019
Q2
$59.3M Sell
223,344
-12,981
-5% -$3.29M 0.11% 178
2019
Q1
$62.9M Buy
236,325
+10,475
+5% +$3.02M 0.12% 161
2018
Q4
$64.7M Sell
225,850
-23,100
-9% -$7.32M 0.14% 138
2018
Q3
$84.3M Sell
248,950
-4,178
-2% -$1.36M 0.16% 125
2018
Q2
$75.3M Buy
253,128
+3,043
+1% +$891K 0.15% 134
2018
Q1
$67.2M Sell
250,085
-13,544
-5% -$3.67M 0.14% 151
2017
Q4
$65.4M Buy
263,629
+3,721
+1% +$919K 0.13% 159
2017
Q3
$63.3M Buy
259,908
+8,827
+4% +$2.16M 0.14% 151
2017
Q2
$60.4M Buy
251,081
+7,310
+3% +$1.66M 0.14% 152
2017
Q1
$50.3M Buy
243,771
+2,910
+1% +$602K 0.12% 176
2016
Q4
$49.1M Buy
240,861
+13,545
+6% +$2.58M 0.12% 170
2016
Q3
$40.2M Buy
227,316
+10,546
+5% +$1.83M 0.11% 193
2016
Q2
$39M Buy
216,770
+7,854
+4% +$1.4M 0.12% 184
2016
Q1
$38.2M Buy
208,916
+7,480
+4% +$1.3M 0.12% 171
2015
Q4
$36M Sell
201,436
-2,051
-1% -$360K 0.12% 175
2015
Q3
$36.4M Sell
203,487
-375
-0.2% -$69.3K 0.12% 165
2015
Q2
$39M Buy
203,862
+12,588
+7% +$2.34M 0.12% 164
2015
Q1
$34.1M Sell
191,274
-11,932
-6% -$1.89M 0.1% 199
2014
Q4
$29.2M Sell
203,206
-888
-0.4% -$121K 0.08% 221
2014
Q3
$26.6M Sell
204,094
-2,748
-1% -$349K 0.08% 222
2014
Q2
$26.4M Sell
206,842
-10,728
-5% -$1.27M 0.08% 238
2014
Q1
$24.5M Sell
217,570
-55,768
-20% -$5.81M 0.07% 257
2013
Q4
$28.2M Sell
273,338
-6,363
-2% -$623K 0.08% 219
2013
Q3
$26.1M Buy
279,701
+1,923
+0.7% +$176K 0.08% 234
2013
Q2
$23.4M Buy
+277,778
New +$21.9M 0.08% 253

Other funds holding HUM

RhumbLine Advisers's HUM Position: Q2 2026 in Review

RhumbLine Advisers increased its Humana (HUM) stake by 7.1% in Q2 2026, buying an estimated $4.89M and bringing the position to 257,527 shares worth $102M. The position accounts for 0.08% of the portfolio, ranked #214.

RhumbLine Advisers first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. The position peaked at $137M in Q4 2022. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • RhumbLine Advisers held 257,527 shares of Humana worth $102M as of Q2 2026.
  • RhumbLine Advisers bought 17,179 Humana shares in Q2 2026, an estimated $4.89M.
  • Humana made up 0.08% of RhumbLine Advisers's portfolio in Q2 2026, its #214 holding.
  • RhumbLine Advisers first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Humana position peaked at $137M in Q4 2022.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.